(Q41752014)

English

Granulocyte-monocyte colony-stimulating-factor augments the interleukin-2-induced cytotoxic activity of human lymphocytes in the absence and presence of mouse or chimeric monoclonal antibodies (mAb 17-1A).

scientific article published on January 1990

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Granulocyte-monocyte colony-stimulating-factor augments the interleukin-2-induced cytotoxic activity of human lymphocytes in the absence and presence of mouse or chimeric monoclonal antibodies (mAb 17-1A). (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

author name string

G Masucci

1

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

P Ragnhammar

2

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

P Wersäll

3

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

H Mellstedt

4

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

publication date

1 January 1990

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

231-235

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The human hematopoietic colony-stimulating factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte-monocyte-colony-stimulating factor augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-idiotypic monoclonal antibody to a T-cell chronic lymphatic leukemia. Characterization of the antibody, in vitro effector functions and results of therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The granulocyte-macrophage colony-stimulating factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. General sedimentation properties of white blood cells in a 1g gravity field

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of IgG Fc receptors in myeloid leukemic cell lines. Effect of colony-stimulating factors and cytokines

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical use of monoclonal antibodies, MAb 17-1A, in the treatment of patients with metastatic colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of human blood mononuclear cell populations in antibody dependent cellular cytotoxicity (ADCC) using two murine (CO17-1A and Br55-2) and one chimeric (17-1A) monoclonal antibodies against a human colorectal carcinoma cell line (SW948).

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chimeric antibodies with 17-1A-derived variable and human constant regions

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine activated killer (LAK) cells in antibody dependent cellular cytotoxicity (ADCC) using MAb 17-1A: a combination of potential usefulness in tumor therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of human natural killer cell function by the combined effects of tumor necrosis factor alpha or interleukin-1 and interferon-alpha or interleukin-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human lymphokine-activated killer cells (LAK cells) as a potential immunotherapeutic modality

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human granulocyte/macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor alpha and interferon in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of human granulocytes and lymphocytes on human fibroblasts in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response of resident murine peritoneal macrophages to in vivo administration of granulocyte-macrophage colony-stimulating factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amplification of IL-2-driven T cell proliferation by recombinant human IL-3 and granulocyte-macrophage colony-stimulating factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2199042

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01789174

1 reference

https://api.fatcat.wiki/v0/release/nhab4fpwzrepdieumbxwoleqvy

30 July 2022

based on heuristic

mapped directly with Wikidata item

Dimensions Publication ID

0 references

release_nhab4fpwzrepdieumbxwoleqvy

1 reference

https://api.fatcat.wiki/v0/release/nhab4fpwzrepdieumbxwoleqvy

30 July 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

https://api.fatcat.wiki/v0/release/nhab4fpwzrepdieumbxwoleqvy

30 July 2022

based on heuristic

mapped directly with Wikidata item

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41752014&oldid=2204755241"